igf-1 lr3 overview active protein-P05019.1 LONG® R³ IGF-I

[DOI] [PubMed] [Google Scholar] 143.Turner B.C., Haffty B.G., Narayanan L., Yuan J., Havre P.A., Gumbs A.A., Kaplan L., Burgaud J.L., Carter D., Baserga R., et al

Since transferrin receptors are an entry point for ASOs, this technology has broader implications, and is not limited to CNS disorders

This is not surprising given that MRS has been historically used to study (a) high-concentration and easily detectable metabolites at lower field strengths, such as N-acetylaspartate, choline, creatine and myo-inositol (Cleeland et al., 2019, Huibregtse et al., 2021), and (b) low-concentration non-GSH metabolites such as gamma-aminobutyric acid and glutamate (Runia et al., 2022)

2019;3(11):nzz108

Molecular mechanisms and metabolomics of natural polyphenols interfering with breast cancer metastasis